ObjectiveTo analyze the clinical effects of transvaginal surgery in treating cesarean scar pregnancy (CSP). MethodsA total of 78 CSP patients were selected, and they were divided into control group (n=39, undergoing evacuation of uterus via hysteroscope and scar pregnancy electrical resection of the lesions) and observation group (n=39, undergoing transvaginal surgery) by the random number table method. The therapeutic effect, surgical related indicators and serum β-human chorionic gonadotropin (β-hCG) level were compared between the two groups. ResultsThe treatment success rate in the observation group was 97.44%, which was higher than that in the control group (74.36%) (P＜0.05). The observation group yielded longer surgery duration, whereas less intraoperative blood loss volume and hospital expenses, and shorter hospital stays (all P＜0.05). After 1 d, 3 d, 7 d and 14 d of surgery, the serum β-hCG level in the observation group was lower than that in the control group (Fintergroup=6 239.000, Pintergroup<0.001), and the serum β-hCG level in both groups interpreted a trend of decreasing over time (Ftime=167.300, Ptime＜0.001). The grouping had interaction effect with time (Finteraction=75.040, Pinteraction＜0.001). ConclusionTransvaginal surgery for CSP has a significant clinical effect, which can quickly decrease serum β-hCG to the normal level, and improve the success rate of surgery, and thus it has a high clinical application value.

无